Adjuvant

The present invention provides a novel adjuvant for polynucleotide vaccines, and in particular the present invention provides immunogenic compositions comprising a polynucleotide encoding an antigen capable of eliciting an immune response and an adjuvant comprising an immunostimulatory quantity of a...

Full description

Saved in:
Bibliographic Details
Main Authors PAPANICOLAOU IRENE, CATCHPOLE IAN RICHARD
Format Patent
LanguageEnglish
Published 24.02.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides a novel adjuvant for polynucleotide vaccines, and in particular the present invention provides immunogenic compositions comprising a polynucleotide encoding an antigen capable of eliciting an immune response and an adjuvant comprising an immunostimulatory quantity of a gemini surfactant, or a derivative thereof.
Bibliography:Application Number: US20060917961